comparemela.com

Latest Breaking News On - Cornelia haag molkenteller - Page 1 : comparemela.com

EG 427 announces final Series A closing, achieving €18 million in total funds raised

EG 427 announces final Series A closing, achieving €18 million in total funds raised
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

France generalCornelia haag molkentellerPhilippe chambonPierre denysHead of urology departmentChief executive officerInvestigational new drugChief medical officerHerpes simplex virus

EG 427 announces €18 million Series A funding

EG 427, a biotechnology company leading the development of pinpoint DNA medicine solutions, has announced the final closing of a Series A financing.

Cornelia haag molkentellerPhilippe chambonInvestigational new drugMarkets amp regulationsBiotech companiesBladder cancer

EG 427 Raises Additional €5M; Brings Total Series A to €18M

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

France generalCornelia haag molkentellerPhilippe chambonChief medical officerHerpes simplex virus

CORRECTING and REPLACING Urovant Sciences Announces Appointment of Sef Kurstjens as Executive Vice President and Chief Medical Officer

Press release content from Business Wire. The AP news staff was not involved in its creation.

South africaUnited statesSumitomo pharmaMaya frutigerAlana darden powellJames robinsonCornelia haag molkentellerAllergan incClinical development at pfizerAgensys incUniversity of the witwatersrand medical schoolAboutsumitovant biopharma ltdUrovant sciences incAstellas pharma incSumitomo pharma co ltdCorporate communications

CORRECTING and REPLACING Urovant Sciences Announces Appointment of Sef Kurstjens as Executive Vice P

IRVINE, Calif. & BASEL, Switzerland (BUSINESS WIRE) Please replace the release with the following corrected version due to multiple revisions to the fifth and sixth paragraphs.The updated release reads:UROVANT SCIENCES ANNOUNCES APPOINTMENT OF SEF KURSTJENS AS EXECUTIVE VICE PRESIDENT AND CHIEF MEDICAL OFFICERUrov.

South africaSumitomo pharmaAlana darden powellJames robinsonCornelia haag molkentellerAllergan incClinical development at pfizerAgensys incUniversity of the witwatersrand medical schoolAboutsumitovant biopharma ltdAstellas pharma incSumitomo pharma co ltdCorporate communicationsUrovant sciencesSumitovant biopharma ltdSef kurstjens

vimarsana © 2020. All Rights Reserved.